From the Research
Inj Zilamac is not a recognized medical term, however, based on the provided evidence, it appears that the question may be referring to Ceftriaxone, a third-generation cephalosporin antibiotic. The typical dosing regimen for Ceftriaxone is 1-2 grams administered intravenously or intramuscularly once daily 1. Patients or caregivers can administer the injection after proper training, and common injection sites include the abdomen, thigh, or upper arm. The medication works by inhibiting bacterial cell wall synthesis, which helps reduce the bacterial load in patients with infections. Side effects may include injection site reactions, upper respiratory tract infections, headache, and diarrhea. Before starting Ceftriaxone, patients should be monitored for signs of allergic reactions and infections during treatment. The medication should be stored at room temperature between 15°C to 30°C (59°F to 86°F) and protected from light.
Some key points to consider when administering Ceftriaxone include:
- It is effective against a broad spectrum of Gram-positive and Gram-negative bacteria, including some anaerobic bacteria 2
- It has a long half-life, which allows for once-daily dosing 2
- It is generally well-tolerated, but may cause adverse reactions such as injection site reactions and diarrhea 3
- It may increase the risk of enterococcal re-infection and prolonged hospitalization in patients with complicated urinary tract infections 4
- A single prophylactic dose of 1g Ceftriaxone may be effective in preventing surgical site infections in patients undergoing laparoscopic cholecystectomy 5
Overall, Ceftriaxone is a effective and well-tolerated antibiotic that can be used to treat a variety of infections, including urinary tract infections, lower respiratory tract infections, and skin and soft tissue infections 1.